Norges Bank’s Vertex Pharmaceuticals Inc Position
Does Norges Bank own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 3.18M shares worth $1.4B in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$1.4B
Q4 2025
Shares
3.18M
% of Portfolio
+0.15%
Quarters Held
23
position exited
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 3.18M | $1.4B | +0.15% |
| Q2 2025 | 3.58M | $1.6B | +0.20% |
| Q1 2025 | 3.46M | $1.4B | +0.23% |
| Q4 2024 | 3.41M | $1.4B | +0.18% |
| Q3 2024 | 2.67M | $930M | +0.19% |
| Q2 2024 | 6.04M | $2.5B | +0.21% |
| Q1 2024 | 2.53M | $797M | +0.17% |
| Q4 2023 | 3.04M | $1.2B | +0.22% |
| Q3 2023 | 2.29M | $663M | +0.18% |
| Q2 2023 | 2.23M | $627M | +0.16% |
| Q4 2022 | 2.45M | $708M | +0.17% |
| Q3 2022 | 2.53M | $458M | +0.10% |
| Q2 2022 | 2.55M | $514M | +0.11% |
| Q1 2022 | 2.64M | $567M | +0.13% |
| Q3 2021 | 2.86M | $779M | +0.21% |
| Q2 2021 | 2.69M | $780M | +0.22% |
| Q1 2021 | 2.54M | $604M | +0.22% |
| Q3 2020 | 2.38M | $404M | +0.12% |
| Q2 2020 | 2.38M | $437M | +0.14% |
| Q1 2020 | 2.38M | $438M | +0.14% |
| Q3 2019 | 2.32M | $448M | +0.15% |
| Q2 2019 | 2.37M | $402M | +0.14% |
| Q1 2019 | 2.43M | $397M | +0.14% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norges Bank’s full portfolio or all institutional holders of VRTX.